SU011248
Drug timelines are a Plus or Pro feature.
32 regulatory and trial events tracked for SU011248, covering 2008-10-16 to 2018-08-22. Get the full timeline:
Most recent: Clinical Trial Update: SU011248 for Platinum-Refractory Urothelial Cancer Evaluation Trial [Phase 2]